Literature DB >> 25820553

Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.

C Marcocci1, M L Brandi2, A Scillitani3, S Corbetta4, A Faggiano5, L Gianotti6, S Migliaccio7, S Minisola8.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25820553     DOI： 10.1007/s40618-015-0261-3

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  88 in total

1.  Primary hyperparathyroidism and pregnancy.

Authors:  Mousumi Som; Jeffrey S Stroup
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-07

2.  The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism.

Authors:  Gregory S Y Ong; John P Walsh; Bronwyn G A Stuckey; Suzanne J Brown; Enrico Rossi; Jennifer L Ng; Hieu H Nguyen; G Neil Kent; Ee Mun Lim
Journal:  J Clin Endocrinol Metab       Date:  2012-06-28       Impact factor: 5.958

Review 3.  Nephrolithiasis and renal calcifications in primary hyperparathyroidism.

Authors:  Lars Rejnmark; Peter Vestergaard; Leif Mosekilde
Journal:  J Clin Endocrinol Metab       Date:  2011-06-06       Impact factor: 5.958

4.  Depression in primary hyperparathyroidism: prevalence and benefit of surgery.

Authors:  Rachel P Espiritu; Ann E Kearns; Kristin S Vickers; Clive Grant; Euijung Ryu; Robert A Wermers
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

5.  Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype.

Authors:  Donatella Malanga; Silvia De Gisi; Miriam Riccardi; Marianna Scrima; Carmela De Marco; Mercedes Robledo; Giuseppe Viglietto
Journal:  Eur J Endocrinol       Date:  2011-11-30       Impact factor: 6.664

6.  Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study.

Authors:  Troels Isaksen; Christian Stoltz Nielsen; Signe Engkjær Christensen; Peter H Nissen; Lene Heickendorff; Leif Mosekilde
Journal:  Calcif Tissue Int       Date:  2011-07-22       Impact factor: 4.333

7.  Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.

Authors:  Signe Engkjaer Christensen; Peter H Nissen; Peter Vestergaard; Lene Heickendorff; Lars Rejnmark; Kim Brixen; Leif Mosekilde
Journal:  Eur J Endocrinol       Date:  2008-09-11       Impact factor: 6.664

Review 8.  Medical management of primary hyperparathyroidism.

Authors:  Aliya A Khan
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

9.  Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  M R Pollak; E M Brown; Y H Chou; S C Hebert; S J Marx; B Steinmann; T Levi; C E Seidman; J G Seidman
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

10.  Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4).

Authors:  Elena Pardi; Stefano Mariotti; Natalia S Pellegata; Katiuscia Benfini; Simona Borsari; Federica Saponaro; Liborio Torregrossa; Antonello Cappai; Chiara Satta; Marco Mastinu; Claudio Marcocci; Filomena Cetani
Journal:  Endocr Connect       Date:  2014-11-21       Impact factor: 3.335
View more
  13 in total

1.  The effect of primary hyperparathyroidism on pancreatic exocrine function.

Authors:  P Sisman; M Avci; A Akkurt; A B Sahin; O O Gul; C Ersoy; E Erturk
Journal:  J Endocrinol Invest       Date:  2017-08-02       Impact factor: 4.256

2.  MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors.

Authors:  Letizia Vannucci; Francesca Marini; Francesca Giusti; Simone Ciuffi; Francesco Tonelli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2017-05-22       Impact factor: 3.633

3.  Mild primary hyperparathyroidism as defined in the Italian Society of Endocrinology's Consensus Statement: prevalence and clinical features.

Authors:  E Castellano; F Tassone; R Attanasio; L Gianotti; M Pellegrino; G Borretta
Journal:  J Endocrinol Invest       Date:  2015-11-30       Impact factor: 4.256

4.  Less is more: time to expand the indications for minimally invasive video-assisted parathyroidectomy.

Authors:  S Bakkar; V Matteucci; C Corsini; S Pagliaro; P Miccoli
Journal:  J Endocrinol Invest       Date:  2017-04-03       Impact factor: 4.256

5.  Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms.

Authors:  A Trombetti; E R Christ; C Henzen; G Gold; M Brändle; F R Herrmann; C Torriani; F Triponez; M Kraenzlin; R Rizzoli; C Meier
Journal:  J Endocrinol Invest       Date:  2016-01-07       Impact factor: 4.256

6.  Clinical presentation and management of patients with primary hyperparathyroidism in Italy.

Authors:  F Saponaro; F Cetani; A Repaci; U Pagotto; C Cipriani; J Pepe; S Minisola; C Cipri; F Vescini; A Scillitani; A Salcuni; S Palmieri; C Eller-Vainicher; I Chiodini; B Madeo; E Kara; E Castellano; G Borretta; L Gianotti; F Romanelli; V Camozzi; A Faggiano; S Corbetta; L Cianferotti; M L Brandi; M L De Feo; A Palermo; G Vezzoli; F Maino; M Scalese; C Marcocci
Journal:  J Endocrinol Invest       Date:  2018-04-03       Impact factor: 4.256

Review 7.  MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders.

Authors:  Jens Bollerslev; Camilla Schalin-Jäntti; Lars Rejnmark; Heide Siggelkow; Hans Morreau; Rajesh Thakker; Antonio Sitges-Serra; Filomena Cetani; Claudio Marcocci
Journal:  Eur J Endocrinol       Date:  2019-06-01       Impact factor: 6.664

8.  Clinical Presentation of Primary Hyperparathyroidism in Older Adults.

Authors:  Elena Castellano; Roberto Attanasio; Alberto Boriano; Giorgio Borretta
Journal:  J Endocr Soc       Date:  2019-10-02

9.  Serum Calcium to Phosphorous (Ca/P) Ratio Is a Simple, Inexpensive, and Accurate Tool in the Diagnosis of Primary Hyperparathyroidism.

Authors:  Bruno Madeo; Elda Kara; Katia Cioni; Silvia Vezzani; Tommaso Trenti; Daniele Santi; Manuela Simoni; Vincenzo Rochira
Journal:  JBMR Plus       Date:  2017-11-02

Review 10.  Physical Activity-Dependent Regulation of Parathyroid Hormone and Calcium-Phosphorous Metabolism.

Authors:  Giovanni Lombardi; Ewa Ziemann; Giuseppe Banfi; Sabrina Corbetta
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.